Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott A Barros

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Pharmacogenomics|September 7, 2005
The importance of applying toxicogenomics to increase the efficiency of drug discoveryScott A Barros
Methods in Molecular Biology (Clifton, N.J.)|May 2, 2008
Predictive toxicogenomics in preclinical discoveryScott A Barros, Rory B Martin
Advanced Drug Delivery Reviews|June 27, 2012
Safety profile of RNAi nanomedicinesScott A Barros, Jared A Gollob
Gene|April 23, 2003
Molecular structure and characterization of a novel murine ABC transporter, Abca13Scott A Barros, Raymond W Tennant, Ronald E Cannon
Nucleic Acid Therapeutics|December 7, 2016
Impact of Oligonucleotide Structure, Chemistry, and Delivery Method on In Vitro CytotoxicityMaja M Janas, Yongfeng Jiang, Mark K Schlegel, et al.
The Journal of Biological Chemistry|November 26, 2008
Activation of protein kinase Czeta increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated transportScott A Barros, Chutima Srimaroeng, Jennifer L Perry, et al.
Nucleic Acid Therapeutics|July 9, 2016
Exposure to siRNA-GalNAc Conjugates in Systems of the Standard Test Battery for GenotoxicityMaja M Janas, Yongfeng Jiang, Richard G Duncan, et al.
Molecular Therapy. Nucleic Acids|November 19, 2014
Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and EfficacyVarun Kumar, June Qin, Yongfeng Jiang, et al.
Nucleic Acid Therapeutics|March 16, 2016
OSWG Recommendations for Genotoxicity Testing of Novel Oligonucleotide-Based TherapeuticsCindy L Berman, Scott A Barros, Sheila M Galloway, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2014
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primatesYizhou Dong, Kevin T Love, J Robert Dorkin, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pharmacogenomics|September 7, 2005
The importance of applying toxicogenomics to increase the efficiency of drug discoveryScott A Barros
Methods in Molecular Biology (Clifton, N.J.)|May 2, 2008
Predictive toxicogenomics in preclinical discoveryScott A Barros, Rory B Martin
Advanced Drug Delivery Reviews|June 27, 2012
Safety profile of RNAi nanomedicinesScott A Barros, Jared A Gollob
Gene|April 23, 2003
Molecular structure and characterization of a novel murine ABC transporter, Abca13Scott A Barros, Raymond W Tennant, Ronald E Cannon
Nucleic Acid Therapeutics|December 7, 2016
Impact of Oligonucleotide Structure, Chemistry, and Delivery Method on In Vitro CytotoxicityMaja M Janas, Yongfeng Jiang, Mark K Schlegel, et al.
The Journal of Biological Chemistry|November 26, 2008
Activation of protein kinase Czeta increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated transportScott A Barros, Chutima Srimaroeng, Jennifer L Perry, et al.
Nucleic Acid Therapeutics|July 9, 2016
Exposure to siRNA-GalNAc Conjugates in Systems of the Standard Test Battery for GenotoxicityMaja M Janas, Yongfeng Jiang, Richard G Duncan, et al.
Molecular Therapy. Nucleic Acids|November 19, 2014
Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and EfficacyVarun Kumar, June Qin, Yongfeng Jiang, et al.
Nucleic Acid Therapeutics|March 16, 2016
OSWG Recommendations for Genotoxicity Testing of Novel Oligonucleotide-Based TherapeuticsCindy L Berman, Scott A Barros, Sheila M Galloway, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 2014
Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primatesYizhou Dong, Kevin T Love, J Robert Dorkin, et al.
Pageof 2